P. J. Mease
A. B. Gottlieb
A. Ogdie
I. Mcinnes
S. D. Chakravarty
E. Rampakakis
A. Kollmeier
X. L. Xu
M. Shawi
F. Lavie
M. Kishimoto
P. Rahman
2Swedish Medical Center/Providence St. Joseph Health and University of Washington, Rheumatology, Seattle, Washington, United States of America
Icahn School of Medicine at Mount Sinai, Department of Dermatology, Mt Sinai, United States of America
University of Pennsylvania School of Medicine, Immunology, Philadelphia, United States of America
University of Glasgow, Institute of Infection Immunity and Inflammation, Glasgow, United Kingdom
Janssen Scientific Affairs, LLC, Immunology, Horsham, United States of America
Drexel University College of Medicine, Rheumatology, Philadelphia, United States of America
McGill University, Department of Psychiatry, Montreal, Canada
Janssen Research & Development, LLC, Immunology, San Diego, CA, United States of America
Janssen Pharmaceutical Companies of Johnson & Johnson, Immunology Global Medical Affairs, Horsham, PA, United States of America
Janssen Cilag Global Medial Affairs, Global Medial Affairs, Issy les Moulineaux, France
Kyorin University School of Medicine, Department of Nephrology and Rheumatology, Mitaka, Japan
Memorial University of Newfoundland, Discipline of Medicine, Division of Rheumatology, St. John’s, Canada
United States
United Kingdom
Canada
France
Japan
N/A
Musculoskeletal
Dermatology
Psoriatic arthritis
C reactive protein
guselkumab (IV)
N/A
Randomized
Cross Over
III
N/A
Abbvie
N/A